Search Results - "Kattan, Joseph Gergi"

Quality-of-life outcomes after total neoadjuvant short course radiotherapy, chemo-immunotherapy, and total mesorectal excision for locally advanced rectal cancer by Shamseddine, Ali, Chehade, Laudy, Kattan, Joseph Gergi, Temraz, Sally Naji, Amarin, Rula, Awabdeh, Tala, Charafeddine, Maya, Al Darazi, Monita, Turfa, Rim

“…63 Background: A growing body of evidence supports total neoadjuvant therapy (TNT) for locally advanced rectal cancer (LARC), however the optimal regimen is…”
Get full text

The results of 3000 Fit: A prospective study led at Saint Joseph University of Beirut by Elkaddoum, Ronaldo, Eid, Roland, Haddad, Fady, Germanos, Myrna, Mehawej, Cybel, Kourie, Hampig Raphael, Kattan, Joseph Gergi

“…Abstract only e15141 Background: In terms of frequency, colorectal cancer (CRC) is the 3rd cancer in Lebanon with 1093 incidences registered in 2015. To this…”
Get full text

Assessment of immunoscore and MRI tumor regression grade to predict complete pathologic response in patients with locally advanced rectal cancer: Data from phase II Averectal study by Shamseddine, Ali, Machmouchi, Ahmad, Natout, Mustafa, Turfa, Rim, Kattan, Joseph Gergi, Temraz, Sally Naji, Tawil, Ayman, Elkhaldi, Mousa, Jaber, Omar, Amarin, Rula, Awabdeh, Tala, Charafeddine, Maya, Al Darazi, Monita, Hussain, Hero

“…212 Background: In patients with locally advanced rectal cancer (LARC), magnetic resonance imaging is the most accurate non-invasive staging tool, enabling…”
Get full text

Results of NGS panel of hereditary breast and ovarian cancer in Lebanese women by Al Ajami, Joseph, Jalkh, Nadine, Moubarak, Ghadi, Eid, Roland, Haddad, Fady, Kattan, Joseph Gergi, Ghosn, Marwan, Atallah, David M., Chouery Khoury, Eliane, Kourie, Hampig Raphael

“…Abstract only e13045 Background: Hereditary breast (BC) and ovarian cancer (OC) genetic alterations are considered the most prevalent among familial cancer. To…”
Get full text

Epidemiologic and histologic characteristics of central nervous system lesions: A 20-year experience of a single institution in Lebanon by Eid, Roland, Hage, Stephanie, Antonios, Ingrid, Moussa, Rita, Khoury, Makram, Haddad, Fady, Kourie, Hampig Raphael, Kesrouani, Carole, Ghorra, Claude, Abadjian, Gerard, Kattan, Joseph Gergi

“…Abstract only e13544 Background: Lesions of the central nervous system (CNS) are a heterogeneous group of tumoral and non-tumoral lesions, benign or malignant,…”
Get full text

High immunoscore as a predictor of outcome in patients who underwent chemoimmuno-therapy in locally advanced rectal cancer: A post-hoc analysis of the correlation between immunoscore and pCR in the Averectal study by Shamseddine, Ali, Khalifeh, Ibrahim Moustafa, Elias, Charbel, Turfa, Rim, Kattan, Joseph Gergi, Mukherji, Deborah, Temraz, Sally Naji, Alqasem, Kholoud, Amarin, Rula, Alawabdeh, Tala, Deeba, Samer, Mohamad, Issa, Daoud, Faiez, Al Masri, Mahmoud, Dabous, Ali, Hushki, Ahmad, Jaber, Omar, Charafeddine, Maya, Farhat, Lama, Tawil, Ayman

“…Abstract only 184 Background: The immunoscore (IS), a prognostic score, was first validated in early colon cancer reflecting the immune response against the…”
Get full text

Short-course radiation followed by mFOLFOX-6 plus avelumab for locally advanced rectal adenocarcinoma by Shamseddine, Ali, Zeidan, Youssef, Khalifeh, Ibrahim Moustafa, Kattan, Joseph Gergi, Turfa, Rim, Mukherji, Deborah, Temraz, Sally Naji, Jamali, Faek, Shaib, Yasser Hani, Soweid, Assaad, Deeba, Samer, Kreidieh, Malek, El Husseini, Ziad zuheir, Charafeddine, Maya, Al Darazi, Monita, Geara, Fady B.

“…Abstract only 139 Background: Total neoadjuvant treatment (TNT) for locally advanced rectal cancer is becoming an accepted approach over the last few years…”
Get full text

Circumvent anxiety of patients (CAP) while receiving chemotherapy at one-day hospital by Kattan, Joseph Gergi, Daher, Alain, Assaker, Lama jaoudat, Jreige, Yolla Tanios, Aintouri, Rachide Jamil, Eid, Rouba

“…Abstract only e20500 Background: Transforming patient anxiety to comfort during chemotherapy delivery is the desire of every cancer care givers. For the first…”
Get full text

EGFR mutation incidence and characteristics in non-squamous lung carcinoma in the Lebanese population by Kattan, Joseph Gergi, Haddad, Fady, Kourie, Hampig Raphael, Naderi, Samah, Rassy, Marc, El Karak, Fadi Rafic, Ghosn, Marwan, Sader-Ghorra, Claude

“…Abstract only…”
Get full text

First-line ribociclib plus letrozole for postmenopausal women with hormone receptor-positive (HR+), HER2-negative (HER2-) advanced breast cancer (ABC): MONALEESA-2 safety results by Janni, Wolfgang, Burris, Howard A., Blackwell, Kimberly L., Hart, Lowell L., Chan, Arlene, Nusch, Arnd, Burdaeva, Olga Nikolaevna, Alba, Emilio, Yardley, Denise A., Bachelot, Thomas Denis, Gil Gil, Miguel J., Richards, Donald A., Sparano, Joseph A., Kattan, Joseph Gergi, Bourgeois, Hugues Pierre, El Karak, Fadi Rafic, Ramaswamy, Bhuvaneswari, Sutradhar, Santosh C., Miller, Michelle Kristine, Conte, Pier Franco

“…Abstract only 1047 Background: In the randomized, phase III MONALEESA-2 study (NCT01958021), first-line therapy with ribociclib (RIB; cyclin-dependent kinase…”
Get full text

A randomized phase II trial of upfront docetaxel and vinorelbine followed by either maintenance oral vinorelbine or observation in patients with HER2-negative locally advanced (LA) or metastatic (M) breast cancer (BC) by Farhat, Fadi Sami, Ghosn, Marwan, Bitar, Nizar, Dehaini, Moussa, Chahine, Georges Y., Mourad, Cynthia, Othman, Ahmed, El-Mouhebb, Mayssam, Kattan, Joseph Gergi

“…Abstract only…”
Get full text

PILLAR-2: A randomized, double-blind, placebo-controlled, phase III study of adjuvant everolimus (EVE) in patients (pts) with poor-risk diffuse large B-cell lymphoma (DLBCL) by Witzig, Thomas E., Tobinai, Kensei, Rigacci, Luigi, Lin, Tongyu, Ikeda, Takashi, Vanazzi, Anna, Hino, Masayuki, Shi, Yuankai, Mayer, Jiri, Costa, Luciano J, Bermudez, Carlos DANIEL, Zhu, Jun, Belada, David, Bouabdallah, Kamal, Kattan, Joseph Gergi, Wu, Cassandra, Fan, Jenna, Louveau, Anne-Laure, Voi, Maurizio, Cavalli, Franco

“…Abstract only…”
Get full text